Sign up to save your podcasts
Or
Share Head & Neck Cancers Treatment Landscape & Algorithm – Dr. Fangdi Sun
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Head & Neck Cancers Treatment Landscape & Algorithm – Dr. Fangdi Sun
In this episode of the Oncology Brothers podcast, we dived into the current treatment landscape for head and neck cancer. We welcomed Dr. Fangdi Sun, a head and neck medical oncologist from Stanford University, to discuss key topics including:
• The importance of initial workup and the role of biomarkers, including HPV and EBV testing.
• Treatment paradigm for early-stage and locally advanced head and neck cancers, focusing on the differences between HPV-positive and HPV-negative disease.
• The evolving role of immunotherapy and the new perioperative approaches in treatment.
• Insights into managing metastatic disease, including the use of PD-L1 scores and systemic therapy options.
• The significance of multidisciplinary collaboration in optimizing patient care.
Whether you're a healthcare professional or simply interested in oncology, this episode provides valuable insights into the complexities of head and neck cancer treatment. Don't miss out on this informative discussion!
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Subscribe to our channel for more episodes as we continue to bridge the gap in oncology!
#HeadAndNeckCancer, #HPV, #Immunotherapy, #MultidisciplinaryCare, #OncologyBrothers
View all episodes
By Oncology Brothers
4.9
4242 ratings
In this episode of the Oncology Brothers podcast, we dived into the current treatment landscape for head and neck cancer. We welcomed Dr. Fangdi Sun, a head and neck medical oncologist from Stanford University, to discuss key topics including:
• The importance of initial workup and the role of biomarkers, including HPV and EBV testing.
• Treatment paradigm for early-stage and locally advanced head and neck cancers, focusing on the differences between HPV-positive and HPV-negative disease.
• The evolving role of immunotherapy and the new perioperative approaches in treatment.
• Insights into managing metastatic disease, including the use of PD-L1 scores and systemic therapy options.
• The significance of multidisciplinary collaboration in optimizing patient care.
Whether you're a healthcare professional or simply interested in oncology, this episode provides valuable insights into the complexities of head and neck cancer treatment. Don't miss out on this informative discussion!
Follow us on social media:
• X/Twitter: https://twitter.com/oncbrothers
• Instagram: https://www.instagram.com/oncbrothers
• Website: https://oncbrothers.com/
Subscribe to our channel for more episodes as we continue to bridge the gap in oncology!
#HeadAndNeckCancer, #HPV, #Immunotherapy, #MultidisciplinaryCare, #OncologyBrothers
More shows like Oncology Brothers: Practice-Changing Cancer Discussions
View all
Journal of Clinical Oncology (JCO) Podcast
39 Listeners
Research To Practice | Oncology Videos
121 Listeners
ASCO Daily News
59 Listeners
Pod Save America
87,868 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
The ONS Podcast
203 Listeners
OncoPharm
187 Listeners
ASCO Guidelines
46 Listeners
OncLive® On Air
23 Listeners
Lung Cancer Considered
27 Listeners
Oncology Today with Dr Neil Love
59 Listeners
Oncology On The Go
4 Listeners
Blood Cancer Talks
51 Listeners
Two Onc Docs
195 Listeners
Oncology for the Inquisitive Mind
4 Listeners